Drug Eluting Balloon Catheters Market
Drug-eluting Balloon Catheters Market Forecasts to 2030 - Global Analysis By Product (Coronary Artery Balloon Catheters and Peripheral Vascular Balloon Catheters), Drug, Material, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $651.0 MN |
|
Projected Year Value (2030) |
US $1343.2 MN |
|
CAGR (2023 - 2030) |
10.9% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Drug-eluting Balloon Catheters Market is accounted for $651.0 million in 2023 and is expected to reach $1,343.2 million by 2030 growing at a CAGR of 10.9% during the forecast period. Medical devices called drug-eluting balloon catheters (DEBs) are used in interventional cardiology to treat peripheral arterial disease (PAD) and coronary artery disease (CAD). The purpose of these catheters is to administer medication straight to the damaged blood vessel walls in order to stop restenosis, or the constriction of blood vessels after angioplasty treatments. With developments in drug coatings, catheter technology, and continuing clinical research focused on improving patient outcomes and safety, the market for drug-eluting balloon catheters is continually changing.
According to the American Heart Association 2021 report, peripheral artery disease (PAD) affects more than 200 million people worldwide and is associated with high mortality and morbidity. Moreover, the increasing geriatric population, which is prone to cardiovascular diseases and growing healthcare spending are projected to bolster market growth.
Market Dynamics:
Driver:
Prevalence of cardiovascular diseases
The number of individuals in need of interventional therapies to control arterial blockages grows in tandem with the frequency of cardiovascular disorders. For these patients, drug-eluting balloon catheters provide an efficient therapeutic alternative that may result in an increase in the number of procedures using these devices. Additionally, healthcare cost is influenced by the financial burden of cardiovascular illnesses, which includes follow-up care, hospital stays, and therapies. Thus drug-eluting balloon catheters are one example of an innovative and successful treatment that may be more widely used if it can be demonstrated to save long-term healthcare expenditures by reducing restenosis and recurring procedures which encourage the growth of the market.
Restraint:
Limited clinical evidence in some lesion types
There may be fewer effective treatment choices available to healthcare practitioners for particular lesion types if there is limited clinical data supporting the use of drug-eluting balloon catheters. This restriction may result in patients with certain arterial lesions not receiving the best care possible, especially if these are thought to be a potentially good alternative but have no solid data to support their use. Even while these systems could be beneficial in some circumstances, they might choose more well-established therapies with more evidence, missing out on chances to improve patient care thereby propel the growth of the market.
Opportunity:
Expanding clinical evidence
Drug-eluting balloon catheters are safe, effective, and have good long-term results; this data supports their use and encourages healthcare practitioners to use them. Increased clinical data demonstrating the advantages of drug-eluting balloon catheters can have a favourable impact on healthcare payers' judgments about reimbursement. More proof of better patient outcomes might support reimbursement rules that are more favourable, increasing market access and device usage.
Threat:
Cost considerations and reimbursement challenges
Patients' access to drug-eluting balloon catheters may be hampered by payment issues, especially in areas or healthcare systems with unfavourable coverage or reimbursement laws. Due to this restriction, patients may not have equal access to cutting-edge therapies, which might have an effect on their prognosis depending on their insurance status or region. Difficulties with reimbursement or hold-ups in receiving positive coverage decisions might hinder drug-eluting balloon catheters market penetration and acceptance.
Covid-19 Impact
Many hospitals and healthcare facilities gave priority to COVID-19 patients when it came to resources during the pandemic's height. Elective operations, including non-urgent cardiac interventions like drug-eluting balloon angioplasty, had to be postponed or cancelled as a result. As a result, the number of procedures performed on the market for these devices decreased. Elective operations and non-urgent interventions showed a steady recovery as vaccination rates rose and healthcare systems adjusted to the epidemic. As a result of several healthcare institutions starting up again, there was an increase in demand for cardiovascular treatments, especially those requiring balloon catheters that release medication.
The coronary artery balloon catheters segment is expected to be the largest during the forecast period
The coronary artery balloon catheters segment is estimated to have a lucrative growth, as these gadgets are intended to unblock or widen coronary arteries in order to replenish blood supply to the heart muscle. In particular, drug-eluting balloon catheters are a kind of catheter that, in order to avoid restenosis, provide medication right to the location of an arterial blockage. Moreover these are becoming more and more popular; as these devices are driven by factors like the need for less invasive procedures, the prevalence of cardiovascular diseases rising, and the fact that drug-eluting balloons reduce restenosis rates more effectively than traditional angioplasty which drives the growth of the market.
The paclitaxel segment is expected to have the highest CAGR during the forecast period
The paclitaxel segment is anticipated to witness the highest CAGR growth during the forecast period, because its usage in drug-eluting balloon (DEB) catheters has drawn a lot of attention and investigation because of worries about its safety, especially in light of possible long-term consequences and a link to higher death rates in patients with peripheral artery disease (PAD). Furthermore, drug-eluting balloon catheters and other paclitaxel-coated goods have seen changes in their market dynamics due to safety concerns surrounding these devices. Thus increased scrutiny, modifications to clinical procedures and conversations about patient selection and long-term safety monitoring have resulted from it.
Region with largest share:
North America is projected to hold the largest market share during the forecast period owing to the availability of several large manufacturers, the introduction of new, technologically sophisticated equipment, and advantageous reimbursement policies are all key contributors to the market share that is seen in North America. For instance, according to estimates from the American Heart Association, more than 500,000 percutaneous coronary procedures including percutaneous transluminal coronary interventions are performed in the United States each year.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to both the rise in healthcare costs and the prevalence of cardiovascular diseases. According to Biomedcentral, almost one in five Chinese people suffer from cardiovascular disease. Furthermore, it is projected that growing disposable income and an older population in nations like China and Japan would fuel demand in the area. The growth of health tourism in developing nations is also contributing to the industry's progress in this sector.
Key players in the market
Some of the key players profiled in the Drug-eluting Balloon Catheters Market include Aachen Resonance GmbH, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik AG, iVascular S.L.U., Lepu Medical Technology (Beijing) Co. Ltd., MedAlliance, Medtronic plc, Biosensors International, Eurocor GmbH, Zhejiang Barty Medical Technology Co.Ltd, Cook Group Incorporated, Terumo Corporation, SurModics Inc, Koninklijke Philips NV, Jotech GmbH, MicroPort Scientific Corporation, Cordis Corporation, Cardionovum GmbH and Abbott Laboratories
Key Developments:
In November 2023, BD launched a new, advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines and other vascular access devices.
In October 2023, Philips OneBlade Partners with College Rivals for an Epic Gaming Journey Enabling Gen Z to ‘Move Fearlessly’ this is the third strategic partnership in a year that aims to strengthen the brand’s commitment to reaching the GenZ audience.
In August 2023, Philips expands local manufacturing of Personal Health products in India to serve local demand, in addition to the beauty and grooming products already being made at the site.
Products Covered:
• Coronary Artery Balloon Catheters
• Peripheral Vascular Balloon Catheters
Drugs Covered:
• Sirolimus
• Paclitaxel
• Other Drugs
Materials Covered:
• Nylon
• Polyurethane
• Other Materials
End Users Covered:
• Ambulatory Surgical Centers
• Catheterization Laboratories
• Hospitals & clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Drug-eluting Balloon Catheters Market, By Product
5.1 Introduction
5.2 Coronary Artery Balloon Catheters
5.3 Peripheral Vascular Balloon Catheters
6 Global Drug-eluting Balloon Catheters Market, By Drug
6.1 Introduction
6.2 Sirolimus
6.3 Paclitaxel
6.4 Other Drugs
7 Global Drug-eluting Balloon Catheters Market, By Material
7.1 Introduction
7.2 Nylon
7.3 Polyurethane
7.4 Other Materials
8 Global Drug-eluting Balloon Catheters Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Catheterization Laboratories
8.4 Hospitals & clinics
8.5 Other End Users
9 Global Drug-eluting Balloon Catheters Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Aachen Resonance GmbH
11.2 B. Braun Melsungen AG
11.3 Becton, Dickinson and Company
11.4 Biotronik AG
11.5 iVascular S.L.U.
11.6 Lepu Medical Technology(Beijing) Co. Ltd.
11.7 MedAlliance
11.8 Medtronic plc
11.9 Biosensors International
11.10 Eurocor GmbH
11.11 Zhejiang Barty Medical Technology Co.Ltd
11.12 Cook Group Incorporated
11.13 Terumo Corporation
11.14 SurModics Inc
11.15 Koninklijke Philips NV
11.16 Jotech GmbH
11.17 MicroPort Scientific Corporation
11.18 Cordis Corporation
11.19 Cardionovum GmbH
11.20 Abbott Laboratories
List of Tables
1 Global Drug-eluting Balloon Catheters Market Outlook, By Region (2021-2030) ($MN)
2 Global Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
3 Global Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
4 Global Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
5 Global Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
6 Global Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
7 Global Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
8 Global Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
9 Global Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
10 Global Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
11 Global Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
12 Global Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
13 Global Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
14 Global Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
15 Global Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
16 Global Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
17 Global Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
18 North America Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
19 North America Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
20 North America Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
21 North America Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
22 North America Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
23 North America Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
24 North America Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
25 North America Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
26 North America Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
27 North America Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
28 North America Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
29 North America Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
30 North America Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
31 North America Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
32 North America Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
33 North America Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
34 North America Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
35 Europe Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
36 Europe Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
37 Europe Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
38 Europe Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
39 Europe Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
40 Europe Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
41 Europe Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
42 Europe Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
43 Europe Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
44 Europe Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
45 Europe Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
46 Europe Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
47 Europe Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
48 Europe Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
49 Europe Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
50 Europe Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
51 Europe Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
52 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
53 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
54 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
55 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
56 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
57 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
58 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
59 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
60 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
61 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
62 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
63 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
64 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
65 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
66 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
67 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
68 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
69 South America Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
70 South America Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
71 South America Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
72 South America Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
73 South America Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
74 South America Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
75 South America Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
76 South America Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
77 South America Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
78 South America Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
79 South America Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
80 South America Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
81 South America Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
82 South America Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
83 South America Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
84 South America Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
85 South America Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
86 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
87 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
88 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
89 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
90 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
91 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
92 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
93 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
94 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
95 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
96 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
97 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
98 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
99 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
100 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
101 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
102 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
